Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Springer Seminars in Immunopathology|February 10, 2000
Th1/Th2 subsets: distinct differences in homing and chemokine receptor expression?U Syrbe, J Siveke, A Hamann
Der Chirurg; Zeitschrift Fur Alle Gebiete Der Operativen Medizen|May 23, 2015
[Delayed complications after pancreatic surgery: Pancreatic insufficiency, malabsorption syndrome, pancreoprivic diabetes mellitus and pseudocysts]U Nitsche, J Siveke, H Friess, et al.
Zeitschrift Fur Gastroenterologie|July 5, 2012
[Paraneoplastic acanthosis nigricans of the esophagus: a case report]M Sarbia, M Ringelhan, J Siveke, et al.
United European Gastroenterology Journal|August 19, 2016
Short-term effects and adverse events of endoscopically applied radiofrequency ablation appear to be comparable with photodynamic therapy in hilar cholangiocarcinomaA Schmidt, M Bloechinger, A Weber, et al.
ESMO Gastrointestinal Oncology|April 17, 2026
Growth differentiation factor-15 (GDF-15) in localized pancreatic adenocarcinoma treated with multiagent chemotherapy: a biomarker analysis from the NEOLAP trial (AIO-PAK-0113)B Kimmel, S T Löhnert, F Wedekink, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 30, 2017
Gemcitabine combined with the monoclonal antibody nimotuzumab is an active first-line regimen in KRAS wildtype patients with locally advanced or metastatic pancreatic cancer: a multicenter, randomized phase IIb studyB Schultheis, D Reuter, M P Ebert, et al.
Pageof 1